Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

by Paul Quintaro, Benzinga Editor
December 18, 2012 4:03 PM | 10 seconds read |
Shares of Zogenix ZGNX rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th. View pdf.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!